News Releases

03.22.2022

Journal of Urology publishes University of Washington First-In-Human clinical trial results from the first 19 subjects treated by BWL. Article selected for the cover of the May edition (press release).

01.24.2022

SonoMotion treats its 40th subject in the Break Wave Feasibility First-In-Human clinical trial.

10.01.2021

SonoMotion secures a $400,000 Commercial Readiness Program (CRP) SBIR grant from the NIH.

11.07.2019

SonoMotion closes $10M Series-B round co-led by Advance MedTech Holdings Pte. Ltd., MedVenture Partners Inc and BioVentures. Link to press release.

08.20.2019

SonoMotion initiates First-In-Human clinical trial of its Break Wave™ stone fragmentation system.

05.01.2019

SonoMotion secures a $3M SBIR Phase IIB grant from the NIH in support of its Break Wave™ First-In-Human clinical trial. Planned sites include UW, UBC, UCSD, Cleveland Clinic and Chesapeake Urology.

03.28.2019

GE Healthcare and SonoMotion sign a second co-development agreement and expand their strategic relationship with an updated OEM agreement.

03.26.2019

SonoMotion receives Health Canada ITA approval to initiate its Break Wave™ First-In-Human clinical trial in Canada.